A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)

CHU de Caen, Caen

Hopital du Bocage, Dijon

University of Virginia Health System, Charlottesville

Hopital Jean Minjoz, Besançon

Greenville Hospital System, Greenville

CHU de Rangueil, Toulouse

Ocala Research Institute, Inc., Ocala

Vanderbilt University Medical Center, Nashville

University of Michigan, Dept. of Internal Medicine, Ann Arbor

University of Chicago - Section of Cardiology, Chicago

Hopital Europeen Georges Pompidou, Paris

Hopital Bichat, Paris

The Methodist Hospital, Houston

Centre Hospitalier de Lagny-Marne La Vallee, Lagny

UMass Memorial Medical Center, Worcester

Foothills Hospital, Calgary

University of Alberta Hospital, Edmonton

Vancouver Hospital & Health Sciences Centre, Vancouver

QE II Health Sciences Centre, New Halifax Infirmary, Halifax

HGH-McMaster Clinic, Hamilton

University of Ottawa Heart Institute, Ottawa

Sunnybrook & Women's College Health Sciences Center, Toronto

St. Michael's Hospital, Toronto

Toronto General Hospital, Toronto

Montreal Heart Institute, Montreal

Hopital du Sacre-Coeur de Montreal, Montreal